Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)

NCT00137280 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1067

Last updated 2018-02-22

Study results available
· View outcomes & findings →

Summary

This project evaluates the implementation and effectiveness of a care model to improve treatment for schizophrenia within the context of diverse VA practices and priorities. The project provides information to VA clinicians and managers about Veterans with schizophrenia or schizoaffective disorder who are overweight and/or who would like to return to competitive work. The project facilitates reorganization of care practices in order to get veterans needed and desired services around wellness and work. The project creates a platform that other clinical and research interventions can build upon to improve care, and is designed to inform a national strategy for implementing evidence-based care in schizophrenia.

Conditions

Interventions

BEHAVIORAL

Collaborative Chronic Illness Care Model

A care model that integrates greater availability of clinical information, reorganizes the practice system and provider roles, fosters care coordination, and focuses on evidence-based protocols--specifically supported employment and wellness services for individuals with schizophrenia.

Sponsors & Collaborators

Principal Investigators

  • Alexander Stehle Young, MD MSHS · VA Greater Los Angeles Healthcare System, West Los Angeles, CA

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-13
Primary Completion
2010-03-05
Completion
2011-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00137280 on ClinicalTrials.gov